Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of HIV drug resistance at antiretroviral treatment failure across regions of Russia.

HIV medicine - 1 Jul 2024

Ozhmegova Ekaterina, Lebedev Aleksey, Antonova Anastasiia, Kuznetsova Anna, Kazennova Elena, Kim Kristina, Tumanov Aleksandr, Bobkova Marina

Abstract excerpt

BACKGROUND: This study aimed to investigate mutations associated with, the causes of, and the conditions that contribute to HIV drug resistance (DR). This research provides crucial insights into the mechanisms through which HIV evades antiretroviral drugs and suggests strategies to counter this phenomenon. Our objective was to assess the prevalence and structure of DR in HIV-1 across various regions in Russia and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Reverse Transcriptase Inhibitors

Share to Russia

Share to Treatment Failure

Share to Viral Load

Source

Identifiers

PMID: 38584123
DOI: 10.1111/hiv.13642

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of HIV drug resistance at antiretroviral treatment failure across regions of Russia.PMID 38584123Read ↗

Patterns of HIV-1 drug resistance among HIV-infected patients receiving first-line antiretroviral therapy in Novosibirsk Region, Russia.Semantic proximity Read ↗

HIV drug resistance among patients experiencing antiretroviral therapy failure in Russia, 2019-2021.Semantic proximity Read ↗

PREVALENCE AND STRUCTURE OF HIV-1 DRUG RESISTANCE AMONG TREATMENT NAÏVE PATIENTS SINCE THE INTRODUCTION OF ANTIRETROVIRAL THERAPY IN THE RUSSIAN FEDERATIONSemantic proximity Read ↗

HIV-1 Drug Resistance among Treatment-Naïve Patients in Russia: Analysis of the National Database, 2006-2022.Semantic proximity Read ↗

Prevalence and Structure of HIV-1 Drug Resistance to Antiretrovirals in the Volga Federal District in 2008-2019.Semantic proximity Read ↗

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.Semantic proximity Read ↗

Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.Semantic proximity Read ↗

Nationwide patterns of HIV drug resistance and high viral load in Sub-Saharan African countries.Semantic proximity Read ↗

HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018–2024Semantic proximity Read ↗

Incidence and types of HIV-1 drug resistance mutation among patients failing first-line antiretroviral therapySemantic proximity Read ↗

Alarming Rise of Primary HIV Drug Resistance in Major Regions of Russia.Semantic proximity Read ↗

HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of IranSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.